Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2852-2863
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2852
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2852
Figure 2 Inflammatory bowel disease questionnaire (IBDQ) score – change from baseline over time (total analysis population).
The difference from baseline in the total IBDQ score was statistically significant for all visits (aP < 0.0001, Wilcoxon signed rank test). Standard deviation is given in brackets.
- Citation: Teich N, Grümmer H, Jörgensen E, Liceni T, Holtkamp-Endemann F, Fischer T, Hohenberger S. Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results. World J Gastroenterol 2020; 26(21): 2852-2863
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2852.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2852